Oxygenta Pharmaceutical Profit & Loss Annual

Trade
BSE: 524636 | NSE: - | ISIN: INE102E01018 | Sector: Biotechnology & Drugs
74.80 +1.70 (2.33%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 39.6430.9960.5252.03
Total Revenue 39.6430.9960.5252.03
Costof Revenue Total 40.9735.2252.6742.30
Gross Profit -1.32-4.237.859.73
Selling/ General/ Admin Expenses Total 5.991.244.604.21
Depreciation/ Amortization 2.662.051.591.20
Unusual Expense( Income) -0.040.73-0.55-2.19
Total Operating Expense 49.5839.2558.3245.52
Operating Income -9.94-8.262.216.51
Interest Inc( Exp) Net- Non- Op Total -15.94-14.70-9.15-17.75
Other Net -2.34-1.65-1.78-1.59
Net Income Before Taxes -13.87-11.37-0.493.14
Provisionfor Income Taxes -10.390.200.120.21
Net Income After Taxes -3.48-11.57-0.612.93
Net Income Before Extra Items -3.48-11.57-0.612.93
Net Income -3.48-11.57-0.612.93
Income Availableto Com Excl Extra Ord -3.48-11.57-0.612.93
Income Availableto Com Incl Extra Ord -3.48-11.57-0.612.93
Diluted Net Income -3.48-11.57-0.612.93
Diluted Weighted Average Shares 3.191.421.271.02
Diluted EPS Excluding Extra Ord Items -1.09-8.15-0.482.87
Diluted Normalized EPS -1.10-7.81-0.760.87
Total Adjustmentsto Net Income -0.00--
Other Operating Expenses Total --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts